Biomarker ID | 1910 |
PMID | 30396985 |
Year | 2018 |
Biomarker | HSP27; prohibitin; GSTP1; fibrinogen β chain; ALDH6A1; A1AT; HSP60; |
Biomarker Basis | Expression Based |
Biomolecule | Protein |
Source | Tissue |
Subjects | Humans |
Regulation | Downregulated in Metastatic PCa |
Odds Ratio/Hazard Ratio/Relative Risk | NA |
Effect on Pathways | NA |
Experiment | Metastatic Prostate Cancer Vs No Prostate Cancer |
Type of Biomarker | Diagnostic |
Cohort | 3 normal prostates, 3 localized prostate cancers, 2 bone metastatic prostate cancer were chosen for analysis |
Senstivity | NA |
Specificity | NA |
AUC | NA |
Accuracy | NA |
Level Of Significance | NA |
Method Used | Immunohistochemistry |
Clinical | No |
Remarks | NA |
Clinical Trial Number | NA |
Degree Of Validity | Validated on independent patient dataset |
Technical Name | NA |